Kairos Pharma KAPA
NYSE KAPA
$0.29 -0.01 (-1.73%)
As of: Aug 21, 2026 · 3:59 PM EDT

Kairos Pharma (KAPA) Operating Income Growth (1y) (2024 - 2025)

Kairos Pharma (KAPA) Operating Income Growth (1y) (2024 - 2025) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Op. Inc Growth (1y) (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn 8.32%
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn 19.82%
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn 145.20%
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn 10.14%
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn 269.85%
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn 1,528.74%
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn -336.63%
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn 99.51%
9 Royalty Pharma 27.27 Bn 26.43 Bn - -36.55%
10 Kairos Pharma 5.39 Mn 55,970.58 - -

Historic Data

Download Data
DateValue
Jun 30, 2025 -555.86%
Mar 31, 2025 -341.11%
Dec 31, 2024 -32.78%
Sep 30, 2024 -33.45%